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Abstract
Introduction
Older people have been reported to be at higher risk of COVID-19 mortality. This study
explored the factors mediating this association and whether older age was associated with
increased mortality risk in the absence of other risk factors.
Methods
In UK Biobank, a population cohort study, baseline data were linked to COVID-19 deaths. Pois-
son regression was used to study the association between current age and COVID-19 mortality.
Results
Among eligible participants, 438 (0.09%) died of COVID-19. Current age was associated
exponentially with COVID-19 mortality. Overall, participants aged�75 years were at 13-fold
(95% CI 9.13–17.85) mortality risk compared with those <65 years. Low forced expiratory
volume in 1 second, high systolic blood pressure, low handgrip strength, and multiple long-
term conditions were significant mediators, and collectively explained 39.3% of their excess
risk. The associations between these risk factors and COVID-19 mortality were stronger
among older participants. Participants aged�75 without additional risk factors were at 4-
fold risk (95% CI 1.57–9.96, P = 0.004) compared with all participants aged <65 years.
Conclusions
Higher COVID-19 mortality among older adults was partially explained by other risk factors.
‘Healthy’ older adults were at much lower risk. Nonetheless, older age was an independent
risk factor for COVID-19 mortality.
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Introduction
COVID-19 is an emerging infectious disease caused by the novel coronavirus SARS-CoV-2
and has a wide spectrum of manifestations ranging from asymptomatic infection to severe
pneumonia and respiratory failure. As of mid-August 2020, the COVID-19 pandemic has
infected over 20 million people globally and caused at least 750,000 deaths [1].
Preliminary reports have shown that older people were at a higher risk of COVID-19 com-
plications with higher rates of hospitalisation, intensive care unit admissions, intubation, and
death [2–4]. Currently, it is unclear whether chronological age per se is an independent risk
factor for severe COVID-19, or simply that risk factors are more common among older adults.
Also, the mechanisms through which older age may predispose to poorer prognosis have yet
to be elucidated. Several hypotheses have been proposed as to why older people might be more
susceptible to severe COVID-19 infection, including a weaker immune response [5], obesity
[6], age-related decline in respiratory function [6], frailty [7], and multimorbidity [8, 9].
These questions cannot be answered using hospital studies due to selection biases in testing
and admission, nor using administrative databases because of insufficient information on con-
founding and mediating factors. Therefore, we used UK Biobank, a large, general population
cohort study with rich pre-infection data, to identify factors that help explain the association
between age and COVID-19 mortality and determine whether age per se is a risk.
Methods
UK Biobank recruited over 502,000 participants aged 37 to 73 years (47 to 85 years as of 1
March 2020) at 22 assessment centres across England, Scotland, and Wales between March
2006 and December 2010. We excluded all participants known to have died prior to 1 March
2020, before the COVID-19 pandemic reached the UK.
UK Biobank received ethical approval from the North West Multi-Centre Research Ethics
Committee (REC reference: 11/NW/03820). All participants gave written informed consent
before enrolment in the study, which was conducted in accord with the principles of the Decla-
ration of Helsinki.
Outcomes
COVID-19 death records were based on death certificates, available on all participants up to
30 June 2020. COVID-19-related deaths were defined as ICD-10 codes U07.1 or U07.2 on the
death certificates.
Exposures
At baseline assessment, biological measurements were taken, and data were collected via both
a self-administered touch-screen questionnaire and research nurse led interview according to
a standardised protocol at a median 11.1 (interqartile range 10.4–11.8) years before 1 March
2020. Current age (on 1 March 2020) was derived from date of, and age at, recruitment and
was trichotomised into <65, 65–74 and 75 years. Ethnicity, smoking, medical history and
medication use were self-reported at baseline. For the present analyses, ethnicity was classified
as white or other, due to insufficient participants in the non-white groups (n = 25,186,<6%).
Smoking status was categorised into current/former smoker and never smoker. Systolic blood
pressure (SBP) were measured at the baseline assessment using automated measurements (or
manual if unavailable), and the mean of available measurements derived. Area-level socioeco-
nomic deprivation was based on the Townsend score of the participant’s home postcode
derived from Census data on: unemployment, non-car ownership, non-home ownership and
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household overcrowding. Higher Townsend scores represent greater socioeconomic depriva-
tion [10].
Body mass index (BMI) was derived from measured body mass in kilograms divided by
height squared, measured in metres. Height was measured, without shoes and socks, using a
Seca 202 height measure. Weight and whole-body fat mass and fat free mass were measured to
the nearest 0.1 kg using the Tanita BC-418 MA body composition analyser.
Lung function was assessed by spirometry using a Vitalograph Pneumotrac 6800 spirome-
ter (Vitalograph, Buckingham, UK). Participants did not perform spirometry if they were
pregnant, on medication for tuberculosis or had a history of: chest infection (in the last
month); detached retina; myocardial infarction; eye, chest or abdominal surgery (in the last
three months); or collapsed lung. The aim was to record two acceptable blows from a maxi-
mum of three attempts. The spirometer software compared the acceptability of the first two
blows and, if acceptable (defined as�5% difference in FVC and FEV1), the third blow was not
required. In the moderation analyses, we used the height-, sex-, and ethnicity-specific pre-
dicted FEV1 value at 65 years of age from the Global Lung Function Initiative (GLI) [11] as the
cut-off value to define normal versus low FEV1, because participants who were 75 years of age
during the pandemic were around 65 years of age at baseline.
The Fried classification uses five criteria: weight loss, exhaustion, physical inactivity, slow
walking speed and low grip strength. Grip strength was measured using a Jamar J00105
hydraulic hand dynamometer and the mean was derived from the right and left hand values
expressed in kilograms. Self-reported walking pace was categorised as slow, average, or brisk.
An adapted version of the frailty classification derived by Fried et al. was used in this study
[12]. Participants were classified as frail if they fulfilled three or more criteria, prefrail if they
fulfilled one or two criteria and robust (non-frail) if they did not fulfil any criteria.
The information collected on long-term conditions (LTCs) during the nurse-led interview
(full list contained in S1 Table) was converted into the total number of LTCs for each
participant.
Statistical analyses
Means and standard deviations were reported for continuous variables and numbers and per-
centages for categorical variables. Poisson regression models with robust standard errors were
used to analyse the associations between risk factors and COVID-19 mortality, with the results
reported as risk ratios (RRs) and 95% confidence intervals (CIs) [13]. Poisson regression mod-
els were used instead of logistic regression because they provide RR estimates which aid clini-
cal interpretation.
We used penalised thin plate regression splines to model the association between age and
COVID-19 mortality as it may not be linear [14]. Splines were chosen over fractional polyno-
mials in capturing deep curvatures [15]. Penalised thin plate regression splines provide more
robust results than cubic splines as knot locations do not need to be chosen [16].
The main analyses were adjusted for potential confounding factors: sex, ethnic group, dep-
rivation index and smoking status. We studied four groups of potential mediators: physical
(BMI, SBP), respiratory (FEV1 and FEV1 / FVC ratio), frailty (non-frail, prefrail and frail), and
number of LTCs. These factors were included as covariates in the Poisson models to determine
whether, and to what extent, the RRs between age and COVID-19 were attenuated. In addi-
tion, mediation analysis under counterfactual framework was also conducted [17]. To avoid
multicollinearity and unnecessary adjustment between potential mediators, potential media-
tors were selected in a stepwise process. Firstly, COVID-19 was regressed by current age, all
potential mediators, and confounding factors in a Poisson model. Only the potential mediators
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reaching statistical significance (α = 0.05) were further investigated. Factors that were of high
effect sizes (RR<0.9 or RR>1.1) were also considered. The selected potential mediators were
then regressed by age and other covariates (mediator model) in either multiple Poisson (for
binary mediators) or linear (for other mediators) models adjusting for each other and for
sociodemographic factors. The outcome and mediator models were then combined to com-
pute the natural indirect effect (NIE) and total effect (TE) for each participant which was then
averaged. Quasi-Bayesian estimation with 1,000 iterations were used for estimating the 95% CI
and p-values of the NIE and TE. Mediation proportion was calculated as NIE / TE.
The potential moderating role of risk factors in the association between age and COVID-19
mortality was studied in a series of subgroup analyses using combinations of age (<64, 65–74,
and�75 years) and risk factors: current/former smokers, low FEV1 (< height-, sex-, and eth-
nicity predicted value at 65 years old [11]), obesity (BMI >30 kg/m2), hypertension (SBP�140
mmHg, DBP�90 mmHG or antihypertensive medication), frailty (prefrail and frail), and�3
LTCs. These variables were categorised for easier interpretation. The interactions between risk
factors and age group were tested using likelihood ratio tests comparing models with and with-
out the interaction terms. Each risk factor was combined with age group and the RR derived
for each permutation referent to participants aged<65 years of age and without the risk factor.
This was repeated for the combinations of age and total number of risk factors.
Missing data were handled using complete case analysis. All analyses were conducted using
R version 4.0.2 with package mgcv and mediation.
Results
Of the 502,506 UK Biobank participants, we excluded 29,295 who died prior to 1 March 2020
and 3,177 who had incomplete data on potential confounding factors, resulting in 470,034 par-
ticipants being included in the analyses of COVID-19 mortality (S1 Fig). Overall, 438 partici-
pants died of COVID-19.
Older particpants were less deprived, less likely to be current smokers, more likely to be
frail, and had higher SBP, lower handgrip strength, poorer lung function, and more LTCs
(Table 1). Participants who died of COVID-19 were older, less likely to be white, more likely
to smoke, be male, obese and frail, and had more LTCs, higher SBP and poorer lung function
(Table 1).
Current age was associated exponentially with COVID-19 mortality (Fig 1). Adjusting for
physical (Model 2), respiratory (Model 3), and LTC (Model 5) covariates attenuated the associ-
ation. There was no evidence of a non-linear association between age and the logarithm of
mortality risk.
After adjusting for potential confounding factors and other age-related risk factors, only
BMI, SBP, handgrip strength, FEV1, and�3 LTCs were significantly associated with COVID-
19 mortality. BMI was excluded in the mediation analysis as it was inversely associated with
age after adjustment for other potential mediators. Therefore, mediation analysis was con-
ducted on FEV1 SBP, handgrip strength, and LTCs. These factors collectively accounted for
39.3% of the association between older age and COVID-19 mortality (Table 2).
There were statistically significant interactions between age group and all risk factors in
relation to COVID-19 mortality, except for frailty. Fig 2 shows the associations with COVID-
19 mortality of different combinations of age and risk factors. Compared with participants
<65 years of age who had never smoked, participants�75 years of age had a higher risk even
if they had never smoked (RR 13.03, 95% CI 7.85–21.62, P<0.0001) and higher still if they had
ever smoked (RR 19.68, 95% CI 12.05–32.14, P<0.0001). A similar pattern was observed for
FEV1, obesity, hypertension, and number of LTCs.
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Table 1. Participant characteristics.
Current age (years) COVID-19 mortality
<65 N = 179,249 65–74 N = 196,290 �75 N = 94,495 Alive N = 469,596 Died N = 438
Mean (SD) current age, years 57.95 (4.04) 69.87 (2.79) 77.17 (1.74) 66.78 (8.09) 73.43 (5.90)
Mean (SD) age at baseline, years 47.42 (4.06) 59.33 (2.96) 66.48 (1.77) 56.22 (8.08) 62.81 (5.81)
Male 79135 (44.15) 86193 (43.91) 44691 (47.29) 209744 (44.66) 275 (62.79)
Ethnic minority 15855 (8.85) 7450 (3.80) 2663 (2.82) 25930 (5.52) 38 (8.68)
Mean (SD) deprivation index -0.97 (3.21) -1.53 (2.96) -1.65 (2.91) -1.34 (3.06) -0.13 (3.48)
Smoking status
Never 108694 (60.80) 105025 (53.70) 47597 (50.65) 261150 (55.81) 166 (38.07)
Previous 46870 (26.22) 73076 (37.36) 40157 (42.73) 159899 (34.17) 204 (46.79)
Current 23212 (12.98) 17473 (8.93) 6224 (6.62) 46843 (10.01) 66 (15.14)
Mean (SD) BMI, kg/m2 27.12 (4.85) 27.53 (4.67) 27.51 (4.29) 27.37 (4.67) 29.34 (5.52)
BMI categories
Underweight 1065 (0.60) 884 (0.45) 369 (0.39) 2315 (0.50) 3 (0.70)
Normal 65202 (36.55) 61309 (31.36) 27297 (29.02) 153724 (32.88) 84 (19.58)
Overweight 70988 (39.80) 84306 (43.13) 43881 (46.65) 198994 (42.57) 181 (42.19)
Obese 41126 (23.06) 48973 (25.05) 22527 (23.95) 112465 (24.06) 161 (37.53)
Mean (SD) SBP, mmHg 130.93 (16.33) 139.74 (18.00) 145.54 (18.49) 137.53 (18.36) 144.99 (18.89)
Mean (SD) handgrip strength, kg 32.83 (11.05) 29.77 (10.80) 28.31 (10.32) 30.65 (10.95) 29.77 (10.35)
Mean (SD) FEV1, L 3.11 (0.77) 2.74 (0.72) 2.50 (0.69) 2.84 (0.77) 2.52 (0.84)
Mean (SD) FEV1/FVC 0.77 (0.06) 0.75 (0.06) 0.74 (0.07) 0.76 (0.06) 0.73 (0.08)
Frailty stages
Non-frail 71093 (51.13) 73334 (48.27) 34384 (46.31) 178687 (48.97) 124 (40.00)
Pre-frail 63825 (45.91) 72785 (47.91) 36840 (49.62) 173288 (47.49) 162 (52.26)
Frail 4113 (2.96) 5811 (3.82) 3027 (4.08) 12927 (3.54) 24 (7.74)
Number of LTCs
0 83896 (46.80) 62178 (31.68) 20861 (22.08) 166858 (35.53) 77 (17.58)
1 57883 (32.29) 66375 (33.81) 30726 (32.52) 154870 (32.98) 114 (26.03)
2 24524 (13.68) 39827 (20.29) 23390 (24.75) 87631 (18.66) 110 (25.11)
3 8583 (4.79) 17662 (9.00) 12141 (12.85) 38303 (8.16) 83 (18.95)
4 2897 (1.62) 6650 (3.39) 4802 (5.08) 14318 (3.05) 31 (7.08)
�5 1466 (0.82) 3598 (1.83) 2575 (2.73) 7616 (1.62) 23 (5.25)
N number; SD standard deviation; SBP systolic blood pressure, BMI body mass index; FEV forced expiratory volume; FVC forced vital capacity; LTC long-term
condition
Numbers presented are n (%) unless otherwise specified
https://doi.org/10.1371/journal.pone.0241824.t001
Fig 1. Association of age with COVID-19 mortality by adjustment schemes. Model 1 (Baseline): Sex, ethnicity, deprivation, duration of follow-up, smoking; Model 2
(Physical): Baseline + BMI, SBP; Model 3 (Respiratory): Baseline + FEV1, FEV1/FVC; Model 4 (Frailty): Baseline + frailty stages; Model 5 (LTC): Baseline + number of
LTCs; BMI body mass index; SBP systolic blood pressure; FEV forced expiratory volume; FVC forced vital capacity; LTC long-term conditions.
https://doi.org/10.1371/journal.pone.0241824.g001
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Fig 3 shows the associations between age group and number of risk factors with COVID-19
mortality. Overall, participants aged�75 years were at 13-fold (95% CI 9.13–17.85) mortality
risk compared with those <65 years. The association between number of risk factors and
COVID-19 mortality was stronger among older participants. Participants aged�75 years with
no additional risk factors (smoking, low FEV1, obesity, hypertension, frailty, and multiple
LTCs) had 12-fold mortality risk (RR 12.13, 95% CI 2.79–52.66, P = 0.0009) compared with
those aged<65 years with no risk factors, and had 4-fold mortality risk (95% CI 1.57–9.96,
P = 0.004) compared with all participants aged<65 years (S2 Table).
Discussion
Principal findings
This study demonstrated an exponential association between age and COVID-19 mortality.
Over one-third of older adults’ excess mortality risk was mediated by poorer lung function,
hypertension, muscle weakness, and multiple LTCs. Among older participants, these factors
were both more common and more strongly associated with higher COVID-19 mortality.
FEV1 is a commonly used marker of respiratory function [18, 19]. It is used to diagnose
chronic obstructive pulmonary disease (COPD) but is also associated with mortality inde-
pendent of clinical disease [18]. FEV1 generally peaks in early adulthood and declines with
age beyond 30 to 40 years of age [19]. However, there is a large variation in the peak value
and age-related rate of decline due, in part, to lifestyle factors such as smoking, obesity, and
physical activity [20]. The mechanism underlying the relationship between FEV1 and
COVID-19 merits further study but may be due to people with poorer FEV1 having less
cardiorespiratory reserve to buffer against the immune-mediated lung response to COVID-
19 infection [6].
LTCs are more common among older adults and have been shown to be associated with
poorer functional health [21] and poorer outcomes in COVID-19 [22, 23]. This is consistent
with other infectious diseases [24–26]. The association between LTCs and increased risk of
COVID-19, as in other infectious diseases, could be related to shared biological pathways such
as chronic low-grade inflammation [27, 28] and attenuated immune response [29].
Strengths and limitations
This study used a large, general population cohort that provided extensive pre-infection data
on sociodemographic factors, physical measurements, LTCs, and respiratory function. There-
fore, we were able to take account of multiple confounders, identify potential mediators and
undertake sub-group analyses.
Table 2. Potential mediators of the association between age�75 years and COVID-19 mortality.
Association with COVID-19 outcomes Regressed by older age Mediation
RR (95% CI) P RR / β† (95% CI) P % P
FEV1
† 0.66 (0.56, 0.78) <0.0001 -0.40 (-0.41, -0.39) <0.0001 16.8 <0.0001
SBP† 1.25 (1.11, 1.42) 0.0002 0.40 (0.39, 0.41) <0.0001 9.9 <0.0001
Handgrip strength† 0.74 (0.61, 0.89) 0.001 -0.19 (-0.19, -0.18) <0.0001 6.5 <0.0001
LTC�3 1.64 (1.27, 2.13) 0.0002 1.22 (1.21, 1.24) <0.0001 6.1 <0.0001
RR relative risk; CI confidence interval; FEV forced expiratory volumne; LTC long-term conditions
†Continuous variables were expressed per 1-SD
Adjusted for sex, ethnicity, deprivation, duration of follow-up, and smoking
https://doi.org/10.1371/journal.pone.0241824.t002
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However, there are several limitations to this study. COVID-related deaths relied on
records on death certificates and it is possible that a small number of participants who
died of COVID-19 were miscoded. However, as we have included both confirmed (ICD-
10 U07.1) and suspected (ICD-10 U07.2) cases, such misclassification should be minimal.
All analysed risk factors, excluding age, were assessed 10 years prior to the COVID-19
Fig 2. Associations between combinations of age group and risk factors and COVID-19 mortality. Adjusted for
sex, ethnicity, deprivation, duration of follow-up; N number; RR relative risk; CI confidence interval; FEV forces
expiratory volume; LTC long-term condition.
https://doi.org/10.1371/journal.pone.0241824.g002
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pandemic and may have changed over time. Any deterioration in these factors over time
is likely to be greater in older age-groups and, therefore, the findings are biased towards
the null. No participants in UK Biobank are currently aged >85 years and therefore our
findings should not be generalised to people over 85 years of age. The UK Biobank cohort
is not completely representative of the general UK population [30, 31]. However, effect
sizes, such as risk ratios reported in this study, are still generalisable [32]. As with other
observational studies, residual confounding may exist. The mediation analyses conducted
assumed no causal relationship between mediators and thus could not detect sequential
mediation.
Comparison with existing studies
The majority of studies on ageing and COVID-19 have been based on hospital samples and
focused on complications or case fatality. It was reported that those who required admission
to intensive care units were on average 15 years older and more likely to have underlying
comorbidities [33]. A recent meta-analyses of 33 studies conducted on a total of 3,027
patients with COVID-19 showed that adults older than 65 years were five times more likely
to become critical or die [23]. In the US, it was estimated that COVID-19 related hospitali-
sation was lowest among 0–17 year-olds and increased almost linearly with age from 2.5 per
100,000 among people 18–49 years to 17.2 per 100,000 among those�85 years [2]. This is in
contrast to our present findings that people aged below 70 shared similar risk. The inconsis-
tency may be due to the lower test rate in the UK where tests have, so far, been largely con-
fined to people with more severe symptoms or to the fact that the minimum current age in
UK Biobank was 50 years.
Fig 3. Association between age group combined with number of risk factors and COVID-19 mortality. Adjusted for sex, ethnicity,
deprivation, duration of follow-up Risk factors included smoking, obesity, hypertension, FEV1, frailty, and number of LTCs�3.
https://doi.org/10.1371/journal.pone.0241824.g003
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Conclusions
Our findings suggest that the risk of COVID-19 mortality is higher in older adults. In this
cohort, over one-third of this excess was due to older adults being more likely to have other
risk factors (e.g. poorer lung function and hypertension) and these risk factors conveying a
stronger risk of COVID-19 death among older people. Nonetheless, older age was associated
with COVID-19 mortality independent of other risk factors.
Currently, everyone over 70 years of age is classified as being at moderate risk from
COVID-19 irrespective of their general health [34]. As such they are recommended to be more
stringent in following social distancing. Our study findings suggest that efforts to protect older
people should prioritise those who have additional risk factors.
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